.
MergerLinks Header Logo

New Deal


Announced

Completed

NextStage-backed Eurobio Scientific completed the acquisition of Genome Diagnostics for €135m.

Synopsis

NextStage-backed Eurobio Scientific, a French group operating in vitro medical diagnostics and life sciences industry, completed the acquisition of Genome Diagnostics, a provider of molecular diagnostics tools, for €135m ($137m). "This operation is transformative for Eurobio Scientific and is fully in line with the development strategy that we have been successfully pursuing for several years and which is based on a direct presence in Europe and an increase in the share of proprietary products. The strong complementarity between our two groups should make it possible to increase the advance of our Group both technologically, geographically and commercially," Denis Fortier, Eurobio Scientific Deputy Managing Director and Co-CEO.

Show Details & Financials

Market Context

Sort

Search a database of more than 250,000 verified dealmakers

Receive automated updates on global transactions

Follow the activity, relationships and transactions of top dealmakers

No credit card required

© COPYRIGHT 2024 MERGERLINKS LIMITED.

ALL RIGHTS RESERVED.

15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.

CONTACT US